Results
|
5621.
|
Osimertinib compared docetaxel-bevacizumab as third-line treatment in EGFR T790M mutated non-small-cell lung cancer. [electronic resource] by
- Nie, Keke
- Zhang, Zhongfa
- Zhang, Chunling
- Geng, Chuanxin
- Zhang, Ling
- Xu, Xiajuan
- Liu, Shichao
- Wang, Songping
- Zhuang, Xingjun
- Lan, Ketao
- Ji, Youxin
Producer: 20190625
In:
Lung cancer (Amsterdam, Netherlands) vol. 121
Availability: No items available.
|
|
5622.
|
|
|
5623.
|
|
|
5624.
|
|
|
5625.
|
|
|
5626.
|
|
|
5627.
|
|
|
5628.
|
|
|
5629.
|
|
|
5630.
|
|
|
5631.
|
Cellular immune profile of patients with advanced cancer before and after taxane treatment. [electronic resource] by
- Tong, A W
- Seamour, B
- Lawson, J M
- Ordonez, G
- Vukelja, S
- Hyman, W
- Richards, D
- Stein, L
- Maples, P B
- Nemunaitis, J
Producer: 20001026
In:
American journal of clinical oncology vol. 23
Availability: No items available.
|
|
5632.
|
|
|
5633.
|
|
|
5634.
|
A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck. [electronic resource] by
- Couteau, C
- Chouaki, N
- Leyvraz, S
- Oulid-Aissa, D
- Lebecq, A
- Domenge, C
- Groult, V
- Bordessoule, S
- Janot, F
- De Forni, M
- Armand, J P
Producer: 19991014
In:
British journal of cancer vol. 81
Availability: No items available.
|
|
5635.
|
|
|
5636.
|
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study. [electronic resource] by
- Alexopoulos, A
- Kouroussis, C
- Malamos, N
- Kakolyris, S
- Kalbakis, K
- Kosmas, C
- Mavroudis, D
- Agelaki, S
- Vlachonicolis, J
- Sarra, E
- Rigatos, G
- Georgoulias, V
Producer: 20020129
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 12
Availability: No items available.
|
|
5637.
|
|
|
5638.
|
|
|
5639.
|
|
|
5640.
|
|